In breast cancer, the overexpression of S100A16 promotes cell proliferation, colony formation, tumor cell invasion, and migration through the epithelial–mesenchymal transition (EMT) pathway and transcription factors such as Notch1 and zinc finger E-box-binding homeobox 1/2 [20]. Here, S100A16 is linked to breast carcinoma.